Arcadia Biosciences Inc

Arcadia Biosciences Inc (RKDA) Stock Analysis

$0.530

+0.018 (+3.33%)At close

Loading chart…
High
0.549
Open
0.500
VWAP
0.53
Vol
157.41K
Mkt Cap
4.25M
Low
0.500
Amount
82.85K
EV/EBITDA, TTM
1.12

Arcadia Biosciences, Inc. is a producer and marketer of plant-based health and wellness products. The Company’s product portfolio includes Zola Coconut Water (Zola) and Agronomic Wheat Traits. Zola is a natural, 100% coconut water. Zola is a non-genetically modified organisms (non-GMO) project verified and only contains 60 calories per serving. Zola flavors include original, original with pulp, espresso, lime and pineapple. The recipe with Zola includes smoothies, desserts, cocktails and mocktails, and bowls. It has developed a portfolio of non-GMO specialty wheat traits to offer healthier, nutrient-rich wheat options while providing the same baking quality, taste, and texture as traditional wheat. Its non-GMO Reduced Gluten High Fiber Wheat has fewer allergenic glutens and higher fiber than traditional wheat, while its non-GMO Extended Shelf-Life Wheat extends the shelf life of milled whole wheat flour.

AI analysis of Arcadia Biosciences Inc (RKDA)

hold

Arcadia Biosciences Inc (RKDA) is currently not a strong buy. The stock is trading at $0.53, down 75.35% year-to-date, and has a forward P/E ratio of 36.63, indicating that while it may be undervalued, significant risks remain.

Analyst Ratings (1)

Hold
0 Buy
1 Hold
0 Sell
Current: 0.53
Low
Average
High

HC Wainwright & Co.

2024-08-21

Price Target

$6

Strong Buy

HC Wainwright & Co.

2024-05-23

Price Target

$6

Strong Buy

HC Wainwright & Co.

2024-04-05

Price Target

$10

Strong Buy

HC Wainwright & Co.

2023-08-28

Price Target

$10

Strong Buy

HC Wainwright & Co.

2023-07-24

Price Target

$15

Strong Buy

Valuation Metrics

The current forward P/E ratio for Arcadia Biosciences Inc (RKDA) is 36.63, compared to its 5-year average forward P/E of 3.99.

Forward P/E

Strongly Overvalued
5Y Average P/E
3.99
Current P/E
36.63
Overvalued
17.99
Undervalued
-10.02

Forward EV/EBITDA

Fair
5Y Average EV/EBITDA
0.36
Current EV/EBITDA
1.12
Overvalued
1.12
Undervalued
-0.41

Forward P/S

Undervalued
5Y Average P/S
0.95
Current P/S
0.16
Overvalued
1.62
Undervalued
0.28

Alphio AI Price Scenarios for RKDA

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%RKDA

$5.40

Scenario price

B

Base

Base · 50%RKDA

$5.18

Scenario price

B

Bear

Bear · 25%RKDA

$5.10

Scenario price

Events Timeline

2026-06-26 (ET)

17:00:00

Arcadia Biosciences Files to Sell 11.92M Shares of Common Stock

2026-06-11 (ET)

21:00:00

Arcadia Biosciences Sells 3,883,496 Shares at $1.03 Each

2026-01-28 (ET)

06:10:00

Arcadia Biosciences Files to Sell 1.67M Shares of Common Stock

2026-01-20 (ET)

06:10:00

Rockwell Medical Sees Q4 Gross Margin Rise to 22%

2026-01-12 (ET)

08:50:00

Arcadia Biosciences Issues Preferred Investment Options, Raises Approximately $2.1M

News

RKDA FAQ — answered by Alphio AI

Arcadia Biosciences, Inc. is a producer and marketer of plant-based health and wellness products. The Company’s product portfolio includes Zola Coconut Water (Zola) and Agronomic Wheat Traits. Zola is a natural, 100% coconut water. Zola is a non-genetically modified organisms (non-GMO) project verified and only contains 60 calories per serving. Zola flavors include original, original with pulp, espresso, lime and pineapple. The recipe with Zola includes smoothies, desserts, cocktails and mocktails, and bowls. It has developed a portfolio of non-GMO specialty wheat traits to offer healthier, nutrient-rich wheat options while providing the same baking quality, taste, and texture as traditional wheat. Its non-GMO Reduced Gluten High Fiber Wheat has fewer allergenic glutens and higher fiber than traditional wheat, while its non-GMO Extended Shelf-Life Wheat extends the shelf life of milled whole wheat flour. It operates in the Consumer Non-Cyclicals sector.

Arcadia Biosciences Inc (RKDA) is currently not a strong buy. The stock is trading at $0.53, down 75.35% year-to-date, and has a forward P/E ratio of 36.63, indicating that while it may be undervalued, significant risks remain.

1 analysts cover RKDA: 0 rate it Buy, 1 Hold and 0 Sell.

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

免費開始